Bill Commons

PA HB 672

in committee

An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage of allergenic protein dietary supplements.

Pennsylvania · 2025-2026 Regular Session (209th General Assembly) · lower

Quick answers

Did PA HB 672 pass?

Not yet. PA HB 672 is in committee as of 2025-02-20 and has not come to a final vote. Latest recorded action (2025-02-20): Referred to Insurance

What is PA HB 672 about?

PA HB 672 is a bill in the 2025-2026 Regular Session (209th General Assembly) titled “An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, providing for coverage of allergenic protein dietary supplements.”.

Who sponsors PA HB 672?

Gina Curry is the primary sponsor of PA HB 672, joined by 10 cosponsors.

Introduced
Latest action
2025-02-20 — Referred to Insurance
Bill type
bill
Last updated

Sponsors

  • Gina Curryprimary
  • Tarah Probstcosponsor
  • Maureen Maddencosponsor
  • Nancy Guenstcosponsor
  • Jose Giralcosponsor
  • Benjamin Sanchezcosponsor
  • Chris Piellicosponsor
  • Jennifer O'Maracosponsor
  • Malcolm Kenyattacosponsor
  • Robert Freemancosponsor
  • Danielle Friel Ottencosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-02-20

    Referred to Insurance

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:13.705233Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=PA&identifier=HB 672. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.